What Is FDA Warning Letter?
An official communication from the FDA to a company or individual that identifies significant regulatory violations and demands corrective action. Warning letters are public records and can trigger marketplace delistings.
Why It Matters for Supplement Brands
An FDA warning letter is one of the most damaging actions a supplement brand can face. These letters are published on the FDA's website, can be picked up by media outlets, may trigger Amazon or retail delistings, and undermine consumer trust. Prevention through proper substantiation and compliance is far cheaper than remediation.
How It Works
The FDA issues warning letters when it identifies violations through:
1. **Facility inspections**: FDA investigators inspect manufacturing facilities and review records. 2. **Label review**: The FDA monitors product labels and websites for prohibited disease claims. 3. **Adverse event reports**: Consumer complaints can trigger FDA scrutiny. 4. **Marketplace monitoring**: The FDA actively monitors e-commerce platforms.
Common violations that trigger warning letters: • Disease claims on labels or websites • Unsubstantiated structure–function claims • cGMP violations in manufacturing • Failure to report serious adverse events • Products containing undeclared drug ingredients
Companies typically have 15 business days to respond with a corrective action plan.
Common Mistakes to Avoid
- ✗Assuming that because the FDA hasn't yet contacted you, your marketing claims are compliant
- ✗Not monitoring your brand's Amazon listings, affiliate sites, and social media for non-compliant claims made by others
- ✗Responding to a warning letter without legal counsel experienced in FDA regulatory matters
- ✗Ignoring a warning letter — the FDA can escalate to injunctions, seizures, or criminal prosecution
Related Terms
Automate Your Substantiation
Nutra Comp turns weeks of manual research into minutes of automated clinical evidence analysis and FDA-compliant claim generation.
Join the Waitlist